Engineered Milk‐Derived Extracellular Vesicles Integrate PCSK9 Silencing and Inflammation Modulation for Hyperlipidemia Therapy
Year: 2026
Type: article
Source: Advanced Healthcare Materials
DOI: 10.1002/adhm.71963
Institutions: Nanjing University of Chinese Medicine, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research, Nanchang University, University of Chinese Academy of Sciences, National Medical Products Administration, National Institutes for Food and Drug Control
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7225804196
